In a landmark move, Rio Tinto ( ASX:RIO,NYSE:RIO,LSE:RIO) has sealed an all-cash deal to acquire US-based Arcadium Lithium (NYSE:ALTM,ASX:LTM) for US$6.7 billion. If successful, the deal will catapult Rio Tinto…
Category:
Investing
-
-
Investing
Black Mountain Drilling Results: First Significant Lithium Intersections in Wyoming; and Base Metals (Cu, Zn and Pb) Potential Identified
by adminChariot Corporation Limited (“Chariot”, “CC9” or the “Company”) is pleased to advise that it has intersected significant zones of strong lithium-tantalum mineralisation in the first three (3) holes (“First Three…
-
Investing
Iron Bear Completes Pilot Pellet Production Run and Produces World Class Direct Reduction Pellets
by adminCyclone Metals Limited (ASX: CLE) (Cyclone or the Company) is pleased to announce that Iron Bear completes pilot pellet production run. HIGHLIGHTS Iron Bear Direct Reduction (DR) pellets achieve world…
-
CSE:NF OTCQX:NFUNF Nuclear Fuels Inc. (CSE: NF) (OTCQX: NFUNF) (‘Nuclear Fuels’ or the ‘Company’) announced today the appointment, effective immediately, of Mr. Brahm Spilfogel to the Board of Directors. Mr.…
-
CleanTech Lithium PLC (‘CTL’, ‘CleanTech Lithium’ or the ‘Company’), an exploration and development company advancing lithium projects in Chile for the clean energy transition, is pleased to announce the results…
-
Investing
Forum Energy Metals to Present at Red Cloud’s Fall Mining Showcase and Top Shelf Partners Commodities Global Expo
by adminJoin Forum Energy Metals (TSXV: FMC) (OTCQB: FDCFF) at Red Cloud’s Fall Mining Showcase being held at the Sheraton Centre Toronto Hotel in Toronto on Wednesday October 16th and Thursday October…
-
Investing
Skyharbour’s Partner North Shore Continues Drill Target Generation at Falcon Uranium Project
by adminSkyharbour Resources Ltd. (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (‘Skyharbour’ or the ‘Company’), is pleased to announce that its partner company, North Shore Uranium (‘North Shore’), has…
-
Investing
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
by adminCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the…
-
Metals Australia Ltd (ASX: MLS) (“Metals Australia” or “the Company”) is pleased to announce that drilling is set to commence to test priority targets identified at the Company’s Big Bell…
-
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has traded at three-year highs in 2024 in response to looming interest rate cuts, breakthrough innovations and increased deals in the space. After dropping to…